Talent Biomedical received registration certificates from Turkish Ministry of Health for Automatic IHC stainer and IHC detection system on August, 2024. It’s a big milestone which will greatly help Talent Biomedical to develop Turkish IHC market. Prior to this, these two products also received NMPA approval in 2018 and CE certification in 2023.

Talent Biomedical will continue to research and develop pathological products with high performance, to serve the global market needs in pathological field.

About Talent Biomedical

In 2017, Talent Biomedical was founded by Dr. Guo who among the first few pioneers in developing polymer IHC detection systems, had been engaging in pathological diagnosis research for more than 30 years.

Through 7 years of development, Talent Biomedical has world class IHC polymer detection system and “high throughput automatic stainer (whole staining process of 144 slides only takes around 3 hours)”, in addition, Talent Biomedical developed more than 300 primary antibodies, as well as ISH products, suitable for clinical IHC applications. For more information, please visit www.talentdiagnostics.com.